Chapter 12 Multifocal and other motor neuropathies

Handbook of Clinical Neurology

Volumn 82, Issue , 2007, Pages 229-245

  Van Den Berg, Leonard H ^a   Franssen, Hessel ^b   Van Asseldonk, Jan Thies H ^a   Van Den Berg Vos, Renske M ^a   Wokke, John H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649392480     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)80015-7     Document Type: Article

References (136)

1. Albers J.W., Donofrio P.D., and Mc Gonagle T.K. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 8 (1985) 528-539
2. Arasaki K., Kusunoki S., Kudo N., and Kanazawa I. Acute conduction block in vitro following exposure to antigan-glioside sera. Muscle Nerve 16 (1993) 587-593
3. Auer R.N., Bell R.B., and Lee M.A. Neuropathy with onion bulb formations and pure motor manifestations. Can J Neurol Sci 16 (1989) 194-197
4. Azulay J.P., Blin O., Pouget J., Boucraut J., Bille-Turc F., Carles G., and Serratrice G. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 44 (1994) 429-432
5. Azulay J.P., Rihet P., Pouget J., Cador F., Blin O., Boucraut J., and Serratrice G. Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 62 (1997) 391-394
6. Barohn R.J., Kissel J.T., Warmolts J.R., and Mendell J.R. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46 (1989) 878-884
7. Benatar M., Willison H.J., and Vincent A. Immune-mediated peripheral neuropathies and voltage-gated sodiums channels. Muscle Nerve 22 (1999) 108-110
8. Bentes C., de Carvalho M., Evangelista T., and Sale -L.^M.L. Multifocal motor neuropathy mimicking motor neuron disease: nine cases. J Neurol Sci 169 (1999) 76-79
9. Beydoun S.R., and Copeland D. Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block. Muscle Nerve 23 (2000) 556-559
10. Biessels G.J., Franssen H., van den Berg L.H., Gibson A., Kappelle L.J., Venables G.S., and Wokke J.H. Multifocal motor neuropathy. J Neurol 244 (1997) 143-152
11. (Pt 1). Bostock H., Sharief M.K., Reid G., and Murray N.M. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 118 (1995) 217-225
12. Bouche P., Moulonguet A., Younes-Chennoufi A.B., Adams D., Baumann N., Meininger V., Leger J.M., and Said G. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 59 (1995) 38-44
13. Brannagan III T.H., Nagle K.J., Lange D.J., and Rowland L.P. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 47 (1996) 674-677
14. Burke D., Kiernan M.C., and Bostock H. Excitability of human axons. Clin Neurophysiol 112 (2001) 1575-1585
15. Busby M., and Donaghy M. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. Neurology 250 (2003) 714-724
16. Cappellari A., Nobile-Orazio E., Meucci N., Scarlato G., and Barbieri S. Multifocal motor neuropathy: a source of error in the serial evaluation of conduction block. Muscle Nerve 19 (1996) 666-669
17. Cappellari A., Nobile-Orazio E., Meucci N., Levi M.G., Scarlato G., and Barbieri S. Criteria for early detection of conduction block in multifocal motor neuropathy (MMN): a study based on control populations and follow-up of MMN patients. J Neurol 244 (1997) 625-630
18. Carpo M., Nobile-Orazio E., Meucci N., Gamba M., Barbieri S., Allaria S., and Scarlato G. Anti-GD1a ganglioside anti-bodies in peripheral motor syndromes. Ann Neurol 39 (1996) 539-543
19. Cavaletti G., Zincone A., Marzorati L., Frattola L., Molteni F., and Navalesi P. Rapidly progressive multifocal motor neuropathy with phrenic nerve paralysis: effect of nocturnal assisted ventilation. J Neurol 245 (1998) 613-616
20. Charles N., Benoit P., Vial C., Bierme T., Moreau T., and Bady B. Intravenous immunoglobulin treatment in multifocal motor neuropathy. Lancet 340 (1992) 182
21. Chaudhry V. Multifocal motor neuropathy. Semin Neurol 18 (1998) 73-81
22. Chaudhry V., Corse A.M., Cornblath D.R., Kuncl R.W., Drachman D.B., Freimer M.L., Miller R.G., and Griffin J.W. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 33 (1993) 237-242
23. Chaudhry V., Corse A.M., Cornblath D.R., Kuncl R.W., Freimer M.L., and Griffin J.W. Multifocal motor neuropathy: electro-diagnostic features. Muscle Nerve 17 (1994) 198-205
24. Claus D., Specht S., and Zieschang M. Plasmapheresis in multifocal motor neuropathy: a case report. J Neurol Neurosurg Psychiatry 68 (2000) 533-535
25. (Suppl). Comi G., Amadio S., Galardi G., Fazio R., and Nemni R. Clinical and neurophysiological assessment of immuno-globulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 57 (1994) 35-37
26. Corbo M., Quattrini A., Lugaresi A., Santoro M., Latov N., and Hays A.P. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 32 (1992) 487-493
27. Cornblath D.R., Kuncl R.W., Mellits E.D., Quaskey S.A., Clawson L., Pestronk A., and Drachman D.B. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 15 (1992) 1111-1115
28. Corse A.M., Chaudhry V., Crawford T.O., Cornblath D.R., Kuncl R.W., and Griffin J.W. Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol 39 (1996) 319-325
29. Donaghy M. Classification and clinical features of motor neurone diseases and motor neuropathies in adults. J Neurol 246 (1999) 331-333
30. Donaghy M., Mills K.R., Boniface S.J., Simmons J., Wright I., Gregson N., and Jacobs J. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 57 (1994) 778-783
31. (Pt 7). Duggins A.J., McLeod J.G., Pollard J.D., Davies L., Yang F., Thompson E.O., and Soper J.R. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122 (1999) 1383-1390
32. Dyck P.J., Brien P.C., Oviatt K.F., Dinapoli R.P., Daube J.R., Bartleson J.D., Mokri B., Swift T., Low P.A., and Windebank A.J. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11 (1982) 136-141
33. Dyck P.J., Daube J., Brien P., Pineda A., Low P.A., Windebank A.J., and Swanson C. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314 (1986) 461-465
34. Ellis C.M., Leary S., Payan J., Shaw C., Hu M., Brien M., and Leigh P.N. Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 67 (1999) 15-19
35. Eurelings M., Notermans N.C., van Es H.W., Franssen H., Ramos L.M.P., Wokke J.H.J., and Van den Berg L.H. MR imaging of the brachial plexus in polyneuropathy associated with monoclonal gammapathy. Muscle Nerve 24 (2001) 1312-1318
36. Feasby T.E., Brown W.F., Gilbert J.J., and Hahn A.F. The pathological basis of conduction block in human neuropathies. J Neurol Neurosurg Psychiatry 48 (1985) 239-244
37. Federico P., Zochodne D.W., Hahn A.F., Brown W.F., and Feasby T.E. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 55 (2000) 1256-1262
38. Feldman E.L., Bromberg M.B., Albers J.W., and Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30 (1991) 397-401
39. Freddo L., Yu R.K., Latov N., Donofrio P.D., Hays A.P., Greenberg H.S., Albers J.W., Allessi A.G., and Keren D. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36 (1986) 454-458
40. Harvey G.K., Toyka K.V., Zielasek J., Kiefer R., Simonis C., and Hartung H.P. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 18 (1995) 388-394
41. (Pt 12). Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., Oka N., Kohara N., Saida T., and Kimura J. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 120 (1997) 2159-2169
42. Hughes R.A. The spectrum of acquired demyelinating polyradiculoneuropathy. Acta Neurol Belg 94 (1994) 128-132
43. Jaspert A., Claus D., Grehl H., and Neundorfer B. Multifocal motor neuropathy: clinical and electrophysiological findings. J Neurol 243 (1996) 684-692
44. Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 27 (2003) 285-296
45. Kaji R., Shibasaki H., and Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 42 (1992) 506-509
46. [see comments]. Kaji R., Oka N., Tsuji T., Mezaki T., Nishio T., Akiguchi I., and Kimura J. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 33 (1993) 152-158
47. (Pt 8). Kaji R., Bostock H., Kohara N., Murase N., Kimura J., and Shibasaki H. Activity-dependent conduction block in multifocal motor neuropathy. Brain 123 (2000) 1602-1611
48. Kapoor R., Davies M., Blaker P.A., Hall S.M., and Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 53 (2003) 174-180
49. Katz J.S., and Saperstein D.S. Asymmetric acquired demyelinating polyneuropathies: MMN and MADSAM. Curr Treat Options Neurol 3 (2001) 119-125
50. Katz J.S., Wolfe G.I., Bryan W.W., Jackson C.E., Amato A.A., and Barohn R.J. Electrophysiologic findings in multifocal motor neuropathy. Neurology 48 (1997) 700-707
51. Katz J.S., Barohn R.J., Kojan S., Wolfe G.I., Nations S.P., Saperstein D.S., and Amato A.A. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 58 (2002) 615-620
52. Kermode A.G., Laing B.A., Carroll W.M., and Mastaglia F.L. Intravenous immunoglobulin for multifocal motor neuropathy. Lancet 340 (1992) 920-921
53. Kiernan M.C., Guglielmi J.M., Kaji R., Murray N.M., and Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125 (2002) 664-675
54. Kinsella L.J., Lange D.J., Trojaborg W., Sadiq S.A., Younger D.S., and Latov N. Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers. Neurology 44 (1994) 1278-1282
55. Kornberg A.J., and Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve 17 (1994) 100-104
56. Kornberg A.J., and Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol 37 Suppl 1 (1995) S43-S50
57. Krarup C., Stewart J.D., Sumner A.J., Pestronk A., and Lipton S.A. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 40 (1990) 118-127
58. Kuwabara S., Cappele -S.^C., Lin C.S., Mogyoros I., Bostock H., and Burke D. Excitability properties of median and peroneal motor axons. Muscle Nerve 23 (2000) 1365-1373
59. Lamb N.L., and Patten B.M. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies. Muscle Nerve 14 (1991) 1021-1027
60. Lange D.J., Trojaborg W., McDonald T.D., and Blake D.M. Persistent and transient 'conduction block' in motor neuron diseases. Muscle Nerve 16 (1993) 896-903
61. Latov N., Hays A.P., Donofrio P.D., Liao J., Ito H., McGinnis S., Konstadoulakis M., Freddo L., Shy M.E., and Manoussos K. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 38 (1988) 763-768
62. Le Forestier N., Chassande B., Moulonguet A., Maisonob T., Schaeffer S., Birouk N., Baumann N., Adams D., Leger J.M., Meininger V., Said G., and Bouche P. Multifocal motor neuropathies with conduction blocks. 39 cases. Rev Neurol (Paris) 153 (1997) 579-586
63. Leger J.M. Multifocal motor neuropathy and chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol 8 (1995) 359-363
64. (Suppl). Leger J.M., Younes-Chennoufi A.B., Chassande B., Davila G., Bouche P., Baumann N., and Brunet P. Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 57 (1994) 46-49
65. Leger J.M., Chassande B., Musset L., Meininger V., Bouche P., and Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 124 (2001) 145-153
66. Lewis R.A.. Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities. Muscle Nerve 22 (1999) 1738-1739
67. Magistris M., and Roth G. Motor neuropathy with multifocal persistent conduction blocks. Muscle Nerve 15 (1992) 1056-1057
68. Menkes D.L., Hood D.C., Ballesteros R.A., and Williams D.A. Root stimulation improves the detection of acquired demyelinating polyneuropathies. Muscle Nerve 21 (1998) 298-308
69. Mezaki T., Kaji R., and Kimura J. Multifocal motor neuropathy and Lewis Sumner syndrome: a clinical spectrum. Muscle Nerve 22 (1999) 1739-1740
70. Molinuevo J.L., Cruz-Martinez A., Graus F., Serra J., Ribalta T., and Valls-Sole J. Central motor conduction time in patients with multifocal motor conduction block. Muscle Nerve 22 (1999) 926-932
71. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 115 (2001)
72. Nobile-Orazio E., Legname G., Daverio R., Carpo M., Giuliani A., Sonnino S., and Scarlato G. Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins (1990) 4-18
73. Nobile-Orazio E., Legname G., Daverio R., Carpo M., Giuliani A., Sonnino S., and Scarlato G. Ann Neurol 28 (1990) 190-194
74. Nobile-Orazio E., Meucci N., Barbieri S., Carpo M., and Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 43 (1993) 537-544
75. Nobile-Orazio E., Cappellari A., Meucci N., Carpo M., Terenghi F., Bersano A., Priori A., Barbieri S., and Scarlato G. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. J Neurol Neurosurg Psychiatry 72 (2002) 761-766
76. O'Hanlon G.M., Paterson G.J., Wilson G., Doyle D., McHardie P., and Willison H.J. Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J Neuropathol Exp Neurol 55 (1996) 184-195
77. O'Hanlon G.M., Paterson G.J., Veitch J., Wilson G., and Willison H.J. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. Acta Neuropathol (Berl) 95 (1998) 605-616
78. O'Leary C.P., Mann A.C., Lough J., and Willison H.J. Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity. Muscle Nerve 20 (1997) 479-485
79. Ogawa-Goto K., Funamoto N., Ohta Y., Abe T., and Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 59 (1992) 1844-1849
80. Oh S.J., Kim D.E., and Kuruoglu H.R. What is the best diag-nostic index of conduction block and temporal dispersion?. Muscle Nerve 17 (1994) 489-493
81. Oh S.J., Claussen G.C., and Kim D.S. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant ofchronic inflammatory demyelinating polyneuropathy?. J Peripher Nerv Syst 2 (1997) 362-369
82. Olney R.K., Lewis R.A., Putnam T.D., and Campellone Jr. J.V. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27 (2003) 117-121
83. Pakiam A.S., and Parry G.J. Multifocal motor neuropathy without overt conduction block. Muscle Nerve 21 (1998) 243-245
84. Paparounas K., O'Hanlon G.M., O'Leary C.P., Rowan E.G., and Willison H.J. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the com-plement cascade without inducing acute conduction blockin vitro. Brain 122 (1999) 807-816
85. Parry G.J. AAEM case report #30: multifocal motor neuropathy. Muscle Nerve 19 (1996) 269-276
86. Parry G.J., and Clarke S. Pure motor neuropathy with mul-tifocal conduction block masquerading as motor neuron disease. Muscle Nerve 8 (1985) 167
87. Parry G.J., and Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 11 (1988) 103-107
88. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 14 (1991) 927-936
89. Pestronk A., Cornblath D.R., Ilyas A.A., Baba H., Quarles R.H., Griffin J.W., Alderson K., and Adams R.N. A treatable multifocal motor neuropathy with antibodies to GM1 gan-glioside. Ann Neurol 24 (1988) 73-78
90. Pestronk A., Adams R.N., Kunel R.W., Drachman D.B., Clawson L.L., and Cornblath D.R. Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuro-muscular disorders. Neurology 39 (1989) 628-633
91. Pestronk A., Chaudhry V., Feldman E.L., Griffin J.W., Cornblath D.R., Denys E.H., Glasberg M., Kunel R.W., Olney R.K., and Yee W.C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 27 (1990) 316-326
92. Prineas J.W., and McLeod J.G. Chronic relapsing polyneuritis. J Neurol Sci 27 (1976) 427-458
93. Pringle C.E., Belden J., Veitch J.E., and Brown W.F. Multifocal motor neuropathy presenting as ophthalmople-gia. Muscle Nerve 20 (1997) 347-351
94. Quattrini A., Lorenzetti I., Sciorati C., Corbo M., Previtali S.C., Feltri M.L., Canal N., Wrabetz L., Nemni R., and Clementi E. Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells. J Neuroimmunol 114 (2001) 213-219
95. Rhee E.K., England J.D., and Sumner A.J. A computer simu-lation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol 28 (1990) 146-156
96. Roberts M., Willison H.J., Vincent A., and Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 38 (1995) 111-118
97. Roth G., Rohr J., Magistris M.R., and Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol 25 (1986) 416-423
98. Sabatelli M., Madia F., Mignogna T., Lippi G., Quaranta L., and Tonali P. Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol 248 (2001) 772-777
99. Sadiq S.A., Thomas F.P., Kilidireas K., Protopsaltis S., Hays A.P., Lee K.W., Romas S.N., Kumar N., van den B.L., and Santoro M. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 40 (1990) 1067-1072
100. Santoro M., Uncini A., Corbo M., Staugaitis S.M., Thomas F.P., Hays A.P., and Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 31 (1992) 385-390
101. Saperstein D.S., Amato A.A., Wolfe G.I., Katz J.S., Nations S.P., Jackson C.E., Bryan W.W., Burns D.K., and Barohn R.J. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 22 (1999) 560-566
102. Saperstein D.S., Katz J.S., Amato A.A., and Barohn R.J. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24 (2001) 311-324
103. Schluep M., and Steck A.J. Immunostaining of motor nerve terminals by IgM M protein with activity against ganglio-sides GM1 and GD1b from a patient with motor neuron disease. Neurology 38 (1988) 1890-1892
104. (Pt 3). Sheikh K.A., Deerinck T.J., Ellisman M.H., and Griffin J.W. The distribution of ganglioside-like moieties in peripheral nerves. Brain 122 (1999) 449-460
105. Shy M.E., Heiman-Patterson T., Parry G.J., Tahmoush A., Evans V.A., and Schick P.K. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement followingimmunotherapy. Neurology 40 (1990) 842-844
106. Sumner A.J. Separating motor neuron diseases from pure motor neuropathies. Multifocal motor neuropathy with persistent conduction block. Adv Neurol 56 (1991) 399-403
107. Sumner A.J., Saida K., Saida T., Silberberg D.H., and Asbury A.K. Acute conduction block associated with experi-mental antiserum-mediated demyelination of peripheral nerve. Ann Neurol 11 (1982) 469-477
108. Takigawa T., Yasuda H., Kikkawa R., Shigeta Y., Saida T., and Kitasato H. Antibodies against GM1 ganglioside affect K and Na currents in isolated rat myelinated nerve fibers. Ann Neurol 37 (1995) 436-442
109. Taylor B.V., Gross L., and Windebank A.J. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 47 (1996) 951-955
110. Taylor B.V., Wright R.A., Harper C.M., and Dyck P.J. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 23 (2000) 900-908
111. Taylor B.V., Dyck P.J., Engelstad J., Gruener G., Grant I., and Dyck P.J. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 63 (2004) 129-137
112. Terenghi F., Cappellari A., Bersano A., Carpo M., Barbieri S., and Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy?. Neurology 62 (2004) 666-668
113. Thomas F.P., Adapon P.H., Goldberg G.P., Latov N., and Hays A.P. Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease. J Neuroimmunol 21 (1989) 31-39
114. Thomas F.P., Thomas J.E., Sadiq S.A., van den Berg L.H., Roelofs R.I., Latov N., and Hays A.P. Human monoclonal IgM anti-Gal(beta 1-3)GalNAc autoantibodies bind to the sur-face of bovine spinal motoneurons. J Neuropathol Exp Neurol 49 (1990) 89-95
115. Traynor B.J., Codd M.B., Corr B., Forde C., Frost E., and Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 57 (2000) 109-113
116. Uncini A., Santoro M., Corbo M., Lugaresi A., and Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16 (1993) 610-615
117. Van Asseldonk J.T.H., van den Berg L.H., van den Berg-Vos R.M., Wieneke G.H., Wokke J.H., and Franssen H. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain 126 (2003) 186-198
118. Van Asseldonk J.T.H., Franssen H., Van den Berg-Vos R.M., Wokke J.H.J., and Van den Berg L.H. Multifocal motor neuropathy. Lancet Neurol 4 (2005) 309-319
119. in press. Van Asseldonk J.T.H., van den Berg L.H., Kalmijn S., Wokke J.H.J., and Franssen H. Axon loss is a prominent determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psych (2005)
120. Van den Berg L.H., Franssen H., and Wokke J.H. Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin. Neurology 45 (1995) 987-988
121. Van den Berg L.H., Kerkhoff H., Oey P.L., Franssen H., Mollee I., Vermeulen M., Jennekens F.G., and Wokke J.H. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59 (1995) 248-252
122. Van den Berg L.H., Lokhorst H., and Wokke J.H. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 48 (1997) 1135
123. (Pt 3). Van den Berg L.H., Franssen H., and Wokke J.H. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 121 (1998) 421-428
124. Van den Berg-Vos R.M., Franssen H., Wokke J.H., van Es H.W., and van den Berg L.H. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 48 (2000) 919-926
125. Van den Berg-Vos R.M., van den Berg L.H., Franssen H., Vermeulen M., Witkamp T.D., Jansen G.H., van Es H.W., Kerkhoff H., and Wokke J.H. Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?. Neurology 54 (2000) 26-32
126. Van den Berg-Vos R.M., Franssen H., Visser J., de Visser M., de Haan R.J., Wokke J.H., and van den Berg L.H. Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment. J Neurol 249 (2002) 330-336
127. Van den Berg-Vos R.M., Franssen H., Wokke J.H., and van den Berg L.H. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intra-venous immunoglobulin maintenance treatment. Brain 125 (2002) 1875-1886
128. Van den Berg-Vos R.M., van den Berg L.H., Visser J., de Visser M., Franssen H., and Wokke J.H. The spectrum of lower motor neuron syndromes. J Neurol 250 (2003) 1279-1292
129. Van den Berg-Vos R.M., Visser J., Franssen H., de Visser M., de Jong J.M., Kalmijn S., Wokke J.H., and van den Berg L.H. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 126 (2003) 1036-1047
130. Van Es H.W., van den Berg L.H., Franssen H., Witkamp T.D., Ramos L.M., Notermans N.C., Feldberg M.A., and Wokke J.H. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 48 (1997) 1218-1224
131. Van Schaik I.N., Bossuyt P.M., Brand A., and Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology 45 (1995) 1570-1577
132. Vucic S., Black K.R., Chong P.S., and Cros D. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology 63 (2004) 1264-1269
133. Vucic S., Dawson K., Sun D., and Cros D. Pure motor mononeuropathy with distal conduction block: an unusual presentation of multifocal motor neuropathy with conduction blocks. Clin Neurophysiol 115 (2004) 2323-2328
134. Willison H.J., Paterson G., Kennedy P.G., and Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol 35 (1994) 471-478
135. Wittstock M., Benecke R., and Zettl U.K. Therapy with intravenous immunoglobulins: complications and side-effects. Eur Neurol 50 (2003) 172-175
136. Yuki N., Yamazaki M., Kondo H., Suzuki K., and Tsuji S. Treatment of multifocal motor neuropathy with a high dosage of intravenous immunoglobulin. Muscle Nerve 16 (1993) 220-221